For Arkansas Measles Exposure Locations, click here.

Reportable by Providers and Laboratories

What is Measles?

Measles, or rubeola, is a highly contagious, acute viral infectious disease caused by the measles virus. Some people think of measles as just a rash and fever that clears up in a few days; however, measles can cause serious health complications, especially in children younger than 5-years-old.

The best protection against measles is the measles, mumps, and rubella (MMR) vaccine. The MMR vaccine provides long-lasting protection against all strains of measles.

Transmission

Measles spreads through the air when an infected person coughs or sneezes. Measles can live for up to 2 hours in an airspace after an infected person leaves an area. If you have measles, up to 90% of the people close to you, who are not protected will also become infected.

Symptoms

Symptoms of measles typically appear around 7 to 14 days after exposure to the virus. Common measles symptoms include:

• High fever
• Cough
• Runny nose
• Red, watery eyes (conjunctivitis)
• Rash that starts on the face and spreads down the body

Measles can cause serious health complications, especially in children younger than 5 years old. Common complications are ear infections and diarrhea. Some people are at a higher risk of experiencing severe complications, including pneumonia and encephalitis.

Patient Management

There is no specific antiviral treatment for measles. Medical care is supportive to help relieve symptoms and address related complications.

• Severe measles cases among children, such as those who are hospitalized, should be treated with vitamin A.
• Infected people should be isolated for 4 days after they develop a rash; airborne precautions should be followed in healthcare settings. For more guidance, please refer to CDC Interim Infection Prevention and Control Recommendations for Measles in Healthcare Settings.

Prevention

The most effective way to prevent measles is through vaccination.

*Because there is evidence of community spread in Faulkner County, vaccine recommendations for anyone living in or traveling to that county and surrounding counties (Cleburne, Conway, Lonoke, Perry, Pulaski, Van Buren and White) have been updated. All children six to 11 months of age can receive a dose of the MMR vaccine, known as a “zero” dose. If children get a “zero” dose of MMR vaccine at six to 11 months of age, they should still be vaccinated with two more doses of MMR vaccine according to the routine schedule at 12 months and then four to six years of age. Anyone over 12 months of age can complete a series of two MMR vaccine doses with the second dose at least 28 days after the first dose.

MMR efficacy against measles

• Two doses of measles vaccine are 97% (range: 67% to 100%) effective at preventing measles.
• One dose is 93% (range: 39% to 100%) effective at preventing measles.

Who Should Get MMR Vaccine

• Children
  • CDC recommends all children get two doses of MMR (measles-mumps-rubella) vaccine.
  • First dose at 12 through 15 months of age
  • Second dose at 4 through 6 years of age.
  • Children can receive the second dose earlier as long as it is at least 28 days after the first dose.
• Students at post-high school educational institutions
  • Students at post-high school educational institutions who do not have presumptive evidence of immunity need two doses of MMR vaccine, separated by at least 28 days.
• Adults
  • Adults who do not have presumptive evidence of immunity should get at least one dose of MMR vaccine. This includes adults who were born after 1957 and were vaccinated prior to 1968 with either an inactivated (killed) measles vaccine or a measles vaccine of unknown type. This recommendation is intended to protect those who may have received the killed measles vaccine, which was available from 1963 to 1967 and was not effective.
  • Certain adults may need 2 doses. Adults who are going to be in a setting that poses a high risk for measles or mumps transmission should make sure they have had two doses separated by at least 28 days. These adults include:
    • Students at post-high school education institutions
    • Healthcare personnel
    • International travelers
• International travelers
  • People 6 months of age and older who will be traveling internationally should be protected against measles. Before any international travel:
    • Infants 6 through 11 months of age should receive one dose of MMR vaccine. Infants who get one dose of MMR vaccine before their first birthday should get two more doses (one dose at 12 through 15 months of age and another dose separated by at least 28 days).
    • Children 12 months of age and older should receive two doses of MMR vaccine, separated by at least 28 days.
    • Teenagers and adults who do not have presumptive evidence of immunity against measles should get two doses of MMR vaccine separated by at least 28 days.
• Healthcare personnel
  • Healthcare personnel should have documented presumptive evidence of immunity, according to the recommendations of the Advisory Committee on Immunization Practices [48 pages]. Healthcare personnel without evidence of immunity should get two doses of MMR vaccine, separated by at least 28 days.
• Women of Childbearing Age
  • Women of childbearing age should check with their doctor to make sure they are vaccinated before they get pregnant. Women of childbearing age who are not pregnant and do not have presumptive evidence of immunity should get at least one dose of MMR vaccine.
  • It is safe for breastfeeding women to receive MMR vaccination. Breastfeeding does not interfere with the response to the MMR vaccine, and the baby will not be affected by the vaccine through breast milk.

Public

• About Measles | Measles (Rubeola) | CDC
• Measles Vaccination | Measles (Rubeola) | CDC
• Measles (one-pager) | Poster
• Measles (one-pager) (Spanish) | Poster (Spanish)

Childcare/School Settings

• Preparing for and Responding to Measles in our Childcare Center
• Preparing for and Responding to Measles in your School

Healthcare Providers

• Clinical Overview of Measles | Measles (Rubeola) | CDC
• Fact Sheet | Spanish
• Report a case of this disease by fax
• Submit a specimen for laboratory testing
  • Miscellaneous Examination Form (HL-06)
• Learn more information about disease reporting
• Diagnosis Decision Tree for Providers
• Think Measles! Brief Infection Control Guidance
• Example of Measles Contact Line List

Community spread of measles has been identified in Faulkner County. If your patient resides in or visits Faulkner County or its adjacent counties (Cleburne, Conway, Lonoke, Perry, Pulaski, Van Buren, and White), please review the following vaccination guidance:

• Measles vaccination recommendations for people who live in or visit a county with measles spread and the adjacent counties
• One-page flyer about these recommendations

Laboratories

• Laboratory Testing for Measles | Measles (Rubeola) | CDC
• Report a case of this disease
• Submit a specimen for laboratory testing
  • Miscellaneous Examination Form (HL-06)
  • Measles Specimen Collection Poster

Resources

• ADH List of Local Health Units
• CDC’s Pink Book
• Communicable Disease Reporting Form
• Mandatory Reportable Disease List
• Measles Diagnosis Decision Tree for Providers
• Measles Vaccination Myths and Facts (IDSA)
• Measles Videos | Measles (Rubeola) | CDC
• MMR Vaccine Information Statement
• MMRV Vaccine Information Statement
• Questions About Measles | Measles (Rubeola) | CDC
• Rules and Regulations

Contact Information

Outbreak Response
4815 W. Markham St., Slot 77
Little Rock, AR 72205
Phone: 501-661-2381
Fax: 501-661-2428